Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / / editor Jan B. Vermorken.
Saved in:
| TeilnehmendeR: | |
|---|---|
| Place / Publishing House: | London, England : : Future Medicine Ltd,, 2013. 2013 |
| Year of Publication: | 2013 |
| Language: | English |
| Series: | Future Medecine,
|
| Online Access: | |
| Physical Description: | 1 online resource (111 pages) :; illustrations. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 01929nam a2200445 i 4500 | ||
|---|---|---|---|
| 001 | 5005092475 | ||
| 003 | MiAaPQ | ||
| 005 | 20200923020339.0 | ||
| 006 | m o d | | ||
| 007 | cr cnu|||||||| | ||
| 008 | 171107t20132013enka ob 001 0 eng d | ||
| 020 | |z 9781780843292 | ||
| 020 | |a 9781780843285 |q (electronic bk.) | ||
| 020 | |a 9781780843278 |q (electronic bk.) | ||
| 035 | |a (MiAaPQ)5005092475 | ||
| 035 | |a (Au-PeEL)EBL5092475 | ||
| 035 | |a (CaPaEBR)ebr11451923 | ||
| 035 | |a (OCoLC)851776810 | ||
| 040 | |a MiAaPQ |b eng |e rda |e pn |c MiAaPQ |d MiAaPQ | ||
| 050 | 4 | |a RC271.M65 |b .M666 2013 | |
| 082 | 0 | |a 615.37 |2 23 | |
| 245 | 0 | 0 | |a Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / |c editor Jan B. Vermorken. |
| 264 | 1 | |a London, England : |b Future Medicine Ltd, |c 2013. | |
| 264 | 4 | |c 2013 | |
| 300 | |a 1 online resource (111 pages) : |b illustrations. | ||
| 336 | |a text |2 rdacontent | ||
| 337 | |a computer |2 rdamedia | ||
| 338 | |a online resource |2 rdacarrier | ||
| 490 | 0 | |a Future Medecine, |x 2047-332X | |
| 504 | |a Includes bibliographical references at the end of each chapters and index. | ||
| 588 | |a Description based on online resource; title from PDF title page (ebrary, viewed Noverber 7, 2017). | ||
| 590 | |a Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
| 650 | 0 | |a Monoclonal antibodies |x Therapeutic use. | |
| 650 | 0 | |a HER-2 gene. | |
| 650 | 0 | |a HER-2 protein. | |
| 655 | 4 | |a Electronic books. | |
| 700 | 1 | |a Vermorken, Jan B., |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment. |d London, England : Future Medicine Ltd, c2013 |h 107 pages |k Future Medecine |z 9781780843292 |
| 797 | 2 | |a ProQuest (Firm) | |
| 856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=5092475 |z Click to View |